+13.1%
GSK vs SCCO
+43.0%
-29.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SCCO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +1.9% | +3.1% | +4.9% |
| 7D | +4.9% | -7.9% | +12.8% | +5.3% |
| 30D | +9.9% | -13.0% | +22.9% | +10.6% |
| 3M | +0.2% | -6.9% | +7.0% | +0.2% |
| 6M | +2.3% | +11.0% | -8.6% | +0.3% |
| YTD | +7.1% | +30.3% | -23.2% | -1.2% |
| 1Y | +13.1% | +45.0% | -31.9% | +2.6% |
| All | +13.1% | +43.0% | -29.8% | +2.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SCCO.
Daily Out/Under-Performance
Portfolio return minus SCCO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SCCO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SCCO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling